[PDF][PDF] Le dépistage du cancer du sein: une polémique qui divise. Breast cancer screening: a dividing controversy

S Khrouf, FL Ksontini, M Ayadi, HBA Rais… - La Tunisie …, 2020 - latunisiemedicale.com
Objectif: Faire une revue de la littérature des publications évaluant l’intérêt du dépistage du
cancer du sein dans le monde et en Tunisie. Méthodes: Nous avons effectué une revue de …

RETRACTED: Systemic therapy in the management of metastatic or advanced salivary gland cancers

A Lagha, N Chraiet, M Ayadi, S Krimi, B Allani, H Rifi… - Oral oncology, 2012 - Elsevier
Salivary gland cancers are very rare tumors. They are characterized by a histologic heterogeneity
and a poor outcome. According to this rarity, few prospective data are available to date…

[HTML][HTML] Granulosa cell tumor of the ovary: a retrospective study of 31 cases and a review of the literature

M Dridi, N Chraiet, R Batti, M Ayadi… - International Journal of …, 2018 - hindawi.com
Background. Adult granulosa cell tumors (AGCTs) are the most common sex cord-stromal
tumors. Unlike epithelial ovarian tumors, they occur in young women and are usually detected …

[PDF][PDF] thérapies ciblées dans le cancer du sein métastatique target therapy for metastatic breast cancer

H Rachdi, A Mokrani, R Batti, M Ayadi… - La Tunisie …, 2018 - latunisiemedicale.com
Le cancer du sein est le premier cancer de la femme dans le monde. Depuis les dernières
estimations en 2008 de l’OMS l’incidence ne cesse d’augmenter et on estime que 30% des …

Evaluation of ovarian reserve before and after chemotherapy

…, S Chtourou, H Hannachi, M Hamdoun, M Ayadi… - Journal of gynecology …, 2021 - Elsevier
Background Progress in oncology has improved patient survival. However, cancer chemotherapy
can be gonadotoxic and affect their fertility. Recourse to fertility preservation before …

Identification of two theranostic biomarker panels for epithelial ovarian cancer

…, W Xu, MH Ahmed, M Stayoussef, H Bouaziz, M Ayadi… - Cytokine, 2023 - Elsevier
Background Epithelial Ovarian cancer (EOC) is the leading cause of death associated with
gynecologic tumors. Because the disease is asymptomatic in early-stage, the majority of …

[HTML][HTML] The management of desmoid tumors: a retrospective study of 30 cases

…, L Charfi, Z Ghodhbani, F Letaief, M Ayadi… - International journal of …, 2020 - hindawi.com
Objectives. Desmoid tumor also called aggressive fibromatosis is a rare type of benign tumor.
It is a mesenchymal malignancy without metastatic potential. The standard management is …

[HTML][HTML] Intra-abdominal cystic lymphangioma in adults: a case series of 32 patients and literature review

…, A Makni, S Boukriba, W Frikha, M Ayadi… - Annals of Medicine and …, 2022 - Elsevier
Introduction Cystic lymphangioma (CL) is a benign tumor originating from the lymph vessels.
Lymphangiomas in the abdominal cavity are extremely rare, particularly in adults. This …

Immune checkpoints as potential theragnostic biomarkers for epithelial ovarian cancer

…, M Stayoussef, H Bouaziz, M Ayadi… - The International …, 2023 - journals.sagepub.com
Background Epithelial ovarian cancer (EOC) is the leading cause of death associated with
gynecologic tumors. EOC is asymptomatic in early stages, so most patients are not diagnosed …

[HTML][HTML] Potential predictive factors for pathologic complete response after the neoadjuvant treatment of rectal adenocarcinoma: a single center experience

F Letaief, M Nasri, M Ayadi, K Meddeb… - Cancer biology & …, 2017 - ncbi.nlm.nih.gov
Objective : To assess the response rate of patients with rectal adenocarcinoma to
neoadjuvant therapy and to identify the predictors of histological regression after neoadjuvant …